Ex Parte Acton et al - Page 3


              Appeal No. 2003-1592                                                                                         
              Application 09/492,032                                                                                       

              Shank (Shank ‘765)                        2,937,765                           May 24, 1960                 
              Shanks (Shanks ‘941)                      3,680,941                           Aug.    1, 1972              
              Estes                                    4,962,574                           Oct.   16, 1990              
              Lee                                      5,152,161                           Oct.     6, 1992             
              Saaf                                     5,678,289                           Oct.   21, 1997              
              Biondo                                   5,727,291                           Mar.  17, 1998               
                     The examiner has advanced the following grounds of rejection on appeal:                               
              claims 1 through 11 and 19 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over                
              Biondo in view of Estes, and further in view of Shanks ‘941 (answer, pages 3-5);                             
              claims 12 through 15 and 26 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over               
              as being unpatentable over Biondo in view of Estes, in view of Shanks ‘941 as applied to claim 1             
              above, and further in view of Shank ‘765 (answer, pages 5-6);                                                
              claim 17 stands rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in view of               
              Estes, in view of Shanks ‘941, in view of Shank ‘765 as applied to claim 12 above, and further in            
              view of Saaf (answer, page 6);                                                                               
              claims 28 and 29 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in                
              view of Lee (answer, pages 6-7);                                                                             
              claims 30 and 31 stands rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in               
              view of Lee as applied to claim 28 above, and further in view of Shanks ‘941 (answer, page 7);               
              claim 43 stands rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in view of               
              Shanks ‘941 (answer, pages 7-8);                                                                             
              claims 44 and 45 stands rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in               
              view of Shanks ‘941 as applied to claim 43 above, and further in view of Lee (answer, page 8);               
              claim 46 stands rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in view of               
              Saaf, and further in view of Shanks ‘941 (answer, pages 8-9); and                                            
              claim 47 stands rejected under 35 U.S.C. § 103(a) as being unpatentable over Biondo in view of               
              Saaf, in further view of Shanks ‘941, as applied to claim 46 above, and further in view of Lee               
              (answer, page 9).                                                                                            
                     Appellants group the appealed claims, stating that the groups of claims are separately                
              patentable (brief, pages 5-6).  We note that groups I through IV and VIII encompass appealed                 
              independent claims 1, 28, 43 and 46 and appealed dependent claim 47, respectively, which are                 
              separately rejected, while groups V through VII each encompass claims representing more than                 
              one ground of rejection.  We find that appellants do not present separate arguments for                      
              patentability in either the brief or the reply brief for individual claims, but refer to groups of           
              claims in arguments that group of grounds of rejection, wherein only the differences between                 
              elements in particular claims are noted and the groups of grounds of rejection are based on                  

                                                           - 3 -                                                           



Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007